LifeVantage Corporation’s Board approved the 2026 New Employee Long-Term Incentive Plan on July 31, 2026. The plan is substantially similar to the 2017 Long-Term Incentive Plan, except that incentive stock options cannot be issued and awards may only be granted to recipients eligible under Nasdaq rules.
The plan was adopted by the Board without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4) as an inducement plan. The Board initially reserved 1,500,000 shares of common stock for awards, which may only be granted to qualifying new hires or rehires where the grant is an inducement material to entering into employment.
BlackRock, Inc. filed an amended Schedule 13G reporting passive ownership of common stock of LifeVantage Corp (LFVN). BlackRock and its reporting business units beneficially own 229,432 LifeVantage common shares, representing 1.8% of the outstanding class.
BlackRock reports sole voting power and sole dispositive power over all 229,432 shares, with no shared voting or dispositive power. Various underlying clients may have rights to dividends or sale proceeds, but no single person has an interest in more than five percent of LifeVantage’s outstanding common shares.
Lifevantage Corp Chief Financial Officer Aure Carl reported a tax-related share disposition on Common Stock. A total of 1,361 shares were used to satisfy tax obligations at a reference price of $6.25 per share. After this tax-withholding disposition, Carl directly holds 155,554 shares of Lifevantage common stock.
Lifevantage Corp Chief Sales Officer Kristen Cunningham reported a tax-withholding disposition of company stock tied to equity compensation. On the reported date, 1,717 shares of common stock were withheld at a price of $6.25 per share to cover tax obligations. After this transaction, she directly holds 131,417 shares of Lifevantage common stock, so her overall ownership remains substantial and the event appears routine and compensation-related rather than an open-market trade.
Lifevantage Corp General Counsel Alissa Neufeld reported a routine tax-related share disposition. On July 1, 2026, 1,342 shares of common stock were delivered at $6.25 per share to satisfy tax obligations, classified as a tax-withholding disposition rather than an open-market trade. Following this transaction, Neufeld directly holds 112,744 shares of Lifevantage common stock.
LifeVantage Corporation reports an amended Schedule 13G showing The Capital Management Corporation (reported by Compliance Officer Pamela C. Simms) beneficially owns 1,878,411 shares of common stock, representing 14.9% of the class. The filing states sole voting power of 1,856,711 shares and sole dispositive power of 1,878,411 shares, with the information provided in the amendment signed on 07/06/2026.
Lifevantage Corp director Darwin Lewis reported an open-market purchase of company stock. On this Form 4, he bought 705 shares of Common Stock at a price of $8.595 per share. Following this transaction, he directly owns 137,268 shares of Lifevantage Corp Common Stock.
Lifevantage Corp director Michael A. Beindorff reported an indirect open-market sale of 10,000 shares of common stock on June 3, 2026. The sale, executed by the Michael A. Beindorff Trust, had a weighted average price of $8.5459 per share, with trades ranging from $8.00 to $8.94.
Following the sale, the trust held 41,625 shares. The filing also shows additional indirect holdings of 5,500 shares held by his spouse and 126 shares held by his spouse as custodian for minor children, plus 27,570 shares held directly by Beindorff.
LFVN submitted a Form 144 notice reporting a proposed sale of 10,000 shares of Common Stock to be sold on NASDAQ with an associated line item of $87,300.00 and an entry of 12,615,822 on the same row dated 06/03/2026. The filing also lists prior equity compensation issuances of 7,191 and 2,809 shares dated 02/07/2022 and 12/07/2022, respectively.
LifeVantage Corporation reported weaker results for the third fiscal quarter ended March 31, 2026. Revenue was $43.7 million, down 25.2% from $58.4 million a year earlier, driven mainly by lower sales of the MindBody GLP-1 System, partly offset by the LoveBiome acquisition.
Gross margin remained high at 79.0%, but operating income declined to $1.7 million from $4.1 million. Net income fell to $1.4 million or $0.11 per diluted share, versus $3.5 million or $0.26. Adjusted EBITDA decreased to $3.2 million from $6.4 million.
Active accounts dropped to 109,000, down 22.1% year over year, reflecting fewer consultants and customers. The company generated $5.5 million of operating cash flow in the first nine months, held $12.5 million in cash with no debt, and raised its quarterly dividend to $0.05 per share, up 11.1%. Management now expects full-year fiscal 2026 revenue, adjusted EBITDA and adjusted EPS to be near the lower end of its prior guidance range.